Paul Klee (1879-1940) is undoubtedly the most notable historical figure to have suffered from systemic sclerosis (scleroderma). In this, the first in a series of vignettes on Klee's illness, I will explore a likely early feature of his condition - Raynaud phenomenon. In subsequent vignettes I will highlight other features of Klee's condition.
OstendorfBMaiburgBSchneiderM[Scleroderma and Paul Klee: Metamorphosis of life and art?].Z Rheumatol2004;63(4):318325Article in German. English translation by Heberbrand VA
2.
SilverRMCaptive of art, not disease: Paul Klee and his illness, scleroderma.Pharos Alpha Omega Alpha Honor Med Soc. 2008;71(1):1624
MeierFMPFrommerKWDinserRet al.EUSTAR Co-authors. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database.Ann Rheum Dis2012;71(8):13551360
5.
van den HoogenFKhannaDFransenJet al.2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.Arthritis Rheum2013;65(11):27372747
6.
WeiszGMAlburyWRMatucci-CerinicMSSc and the 2013 diagnostic criteria: the case of Paul Klees manual pathology and dysgraphia.Clin Rheumatol2014;33(11):16711674
